Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06633198 · ClinicalTrials.gov registry record · Early Phase 1

Heat, Microvascular Function and Aging

A Early Phase 1 study of Aging, sponsored by William Hughes.

Recruiting
Registry status
Early Phase 1
Development phase
20
Enrollment target
1
Study location

NCT06633198 is a Early Phase 1 study of Aging that is actively recruiting participants, run by William Hughes. The registered enrollment target is 20 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06633198, a Early Phase 1 study of Aging, is actively recruiting participants, sponsored by William Hughes.

RECRUITING
Registry status
Early Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Vascular dysfunction is a common factor in many chronic debilitating diseases, contributing to morbidity and mortality. With the onset of chronic disease or exposure to stress, the vasculature displays an inability to adequately respond to increased blood flow demands, manifesting in a reduced ability or altered mechanism of vasodilation. Aging is an independent risk factor in the development of cardiovascular disease, and reduces vasodilator capacity, or alters the mechanism by which vasodilation occurs in multiple vascular beds. Chronic exercise/physical activity is one of the most potent ways to enhance vascular function, resulting in favorable outcomes such as reductions in blood pressure, and improved ability to perform activities of daily living. Barriers to exercise or failure of long-term adherence preclude many populations from the cardiovascular benefits of exercise, thus further enhancing cardiovascular risk. Avenues to mimic blood flow patterns observed with exercise may exert beneficial effects without the need for the ability to exercise. Recent evidence has demonstrated that passive heat therapy, or chronic heat exposure (\~ +1°C in core temperature) results in reductions in major adverse cardiovascular events, blood pressure and improved large artery endothelial function, primarily through preservation of large artery function in response to vascular stress. It is unclear whether microvascular function is augmented in response to acute heat exposure, or whether this can protect against vascular insults particularly in older adults. Some preliminary evidence in humans suggest that autophagy, a cell recycling process is involved in the beneficial cardiovascular effects, as short-term heat exposure upregulates markers of autophagy. Previous evidence from our lab indicates that autophagy governs the mechanism by which microvascular vasodilation occurs. The role of autophagy in mediating the beneficial effects of passive heating is unknown.

Conditions Studied

Interventions

  • PROCEDURE Passive Heating
  • DRUG L-NAME

Study Locations (1)

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-05-01
Est. Completion 2028-12-31
Phase Early Phase 1

Sponsor

William Hughes

1 total trials

What the Registry Record Tells You About NCT06633198

The ClinicalTrials.gov registry entry for NCT06633198 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is William Hughes, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Passive Heating is the first listed.

NCT06633198 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06633198 about?

NCT06633198 is a clinical study titled "Heat, Microvascular Function and Aging". Vascular dysfunction is a common factor in many chronic debilitating diseases, contributing to morbidity and mortality. With the onset of chronic disease or exposure to stress, the vasculature displays an inability to adequately respond to increased blood flow demands, manifesting in a reduced abili...

What is the current status of trial NCT06633198?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2025-05-01. Estimated completion is 2028-12-31.

What conditions does trial NCT06633198 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT06633198?

The interventions under investigation include: Passive Heating (PROCEDURE), L-NAME (DRUG).

Who is sponsoring clinical trial NCT06633198?

This trial is sponsored by William Hughes, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06633198 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.